Monalizumab
Monalizumab is a monoclonal antibody that targets the NKG2A receptor, which is an inhibitory receptor found on natural killer cells and some T cells. It is being investigated for its potential use in cancer immunotherapy.
Mechanism of Action[edit]
Monalizumab works by blocking the interaction between NKG2A and its ligand, HLA-E. NKG2A is an inhibitory receptor that, when engaged, can dampen the immune response. By inhibiting this interaction, monalizumab can enhance the activity of natural killer cells and T cells, promoting a stronger immune response against cancer cells.
Clinical Development[edit]
Monalizumab is currently undergoing clinical trials to evaluate its efficacy and safety in treating various types of cancer, including head and neck cancer, ovarian cancer, and colorectal cancer. Early studies have shown promise, with some patients experiencing tumor shrinkage and improved survival rates.
Potential Benefits[edit]
The use of monalizumab in cancer therapy offers several potential benefits:
- Enhanced Immune Response: By blocking the inhibitory signals, monalizumab can potentiate the body's natural immune response against tumors.
- Combination Therapy: Monalizumab is being studied in combination with other immunotherapies, such as PD-1 inhibitors, to assess synergistic effects.
- Broad Applicability: The mechanism of action suggests that monalizumab could be effective against a wide range of cancers.
Side Effects[edit]
As with many immunotherapies, monalizumab can cause immune-related side effects. These may include:
- Fatigue
- Fever
- Skin rash
- Gastrointestinal disturbances
Patients receiving monalizumab are closely monitored for these and other potential adverse effects.
Research and Development[edit]
Monalizumab is being developed by Innate Pharma in collaboration with AstraZeneca. The ongoing research aims to better understand the optimal use of monalizumab in cancer treatment and to identify which patient populations may benefit the most.
Also see[edit]
| Immunology | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This immunology-related article is a stub.
|
| Cancer treatment | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
